Warabi et al.
103
virulence. The TTSS, which forms a syringe-like pore that
spans both bacterial and host cell membranes, consists of
more than 20 proteins. Deleting or mutating any part of the
TTSS significantly reduces the virulence of the affected E.
coli. Non-pathogenic intestinal E. coli do not have TTSSs.
The TTSS is considered an attractive target for the devel-
opment of new antibiotics that would selectively target
pathogenic gram negative bacteria but would not harm the
ordinary microflora that do not possess this virulence mech-
anism (1, 7–9). An added benefit of this type of hypothetical
antibacterial agent is that by targeting a virulence mecha-
nism, there would be little or no selective pressure for viabil-
ity, potentially reducing the development of resistance. No
TTSS inhibitors were known at the outset of our research.
Consequently, there was a significant need to discover TTSS
inhibitors that could be used to provide proof principle dem-
onstrations and drug leads for this novel approach to treating
important infectious diseases.
Marine sponges, which are the richest source of bioactive
marine natural products (10, 11), are constantly exposed to
bacteria in seawater and it has frequently been proposed that
they contain chemical agents that have evolved to prevent
pathogenic bacteria from infecting them (12, 13). We have
screened a library of crude extracts from marine sponges for
their ability to inhibit type III secretion of E. coli secreted
proteins (Esps) by EPEC without affecting the growth or
general secretion of the bacterium (1). Two extracts showed
promising activity in the screen. Recently, we reported the
structure of caminoside A, an antimicrobial glycolipid iso-
lated from the Caribbean sponge Caminus sphaeroconia that
ural products into individual components failed. To facilitate
purification of the mixture, it was first methylated with
(trimethylsilyl)diazomethane and then acetylated with
Ac O–pyridine in the presence of DMAP. Reversed-phase
2
HPLC separation of the mixture of derivatized natural prod-
ucts gave a pure peracetylpachymoside A methyl ester (2) as
a colourless glass.
Peracetylpachymoside A methyl ester (2) gave a [M +
+
Na] ion at m/z 2333.9639 in the ESI-HR-MS consistent
with a molecular formula of C106H159NO54 (calcd. for
1
2
13
C105 CH159NO Na, 2333.9658), requiring 28 sites of
54
1
3
unsaturation. The C NMR spectrum of 2 (100 MHz) re-
corded in C D showed the same general features of a glyco-
6
6
lipid observed in the spectrum of the natural product
mixture. Thus, it was possible to attribute clusters of peaks
to ester or amide carbonyls (δ 168–170), monosaccharide
anomeric carbons (δ 100–102), carbinol methines and
methylenes (δ 67–81), methyl groups attached to O or N (δ
4
9–52), acetate methyl carbons (δ 29–31), and a significant
1
saturated aliphatic fragment (δ 14–43). The H NMR spec-
trum of 2 was very congested at 500 MHz so all of the H
1
1
D and 2D data used in the structure elucidation was re-
corded at 800 MHz in C D , which gave excellent disper-
6
6
sion.
The first step in the structure elucidation of 2 involved
chemical degradation of the mixture of natural pachymo-
sides to liberate the individual monosaccharides. Treatment
of the pachymoside mixture with acetyl chloride in dry
MeOH cleaved the glycosidic linkages and converted the
individual monosaccharides into mixtures of α- and β-
methylglycopyranosides. After removal of the reagents in
was the first compound active in the TTSS inhibition screen
4
(
14, 15). The second active extract came from the sponge
vacuo, the resulting residue was acetylated with Ac O in
2
Pachymatisma johnstonia (Bowerbank, 1842) collected
along the coast of the Isle of Mann. Bioassay-guided frac-
tionation of the P. johnstonia extract yielded a complex fam-
ily of glycolipids that were active in the TTSS assay. The
structure elucidation of pachymoside A (1), a novel glyco-
lipid that is a representative member of this family, is de-
scribed below.
pyridine and a catalytic amount of DMAP to give the pera-
cetylated methylglycosides of the individual monosaccha-
rides. Fractionation of the peracetylated methylglycosides
via reversed-phase HPLC gave an inseparable mixture of
methyl 2,3,4,6-tetra-O-acetyl-α-glucopyranoside (3) and
methyl 2,3,4,6-tetra-O-acetyl-α-galactopyranoside (4) in a
ratio of ≈2:1, respectively. The difference in intensities of
the resonances for each of 3 and 4 made it possible to iden-
tify each of the component compounds by analysis of the 1D
and 2D NMR data obtained for the mixture. To confirm the
assigned structures of 3 and 4, authentic samples of D-
glucose and D-galactose were converted into their peractyl-
ated methyl α-glycopyranosides and the NMR chemical
shifts of the authentic compounds were compared with the
degradation products. Chiral GC analysis of the alditol ace-
tates prepared from authentic L- and D-glucose and D-
galactose and the alditol acetates prepared from the mono-
saccharides obtained by aqueous hydrolysis of the pachy-
moside mixture showed that the glucose and galactose
residues in the pachymosides had the D configuration.
Results and discussion
The TTSS inhibitory fraction obtained from an initial
Sephadex LH20 chromatographic separation (eluent: MeOH)
of the crude P. johnstonia extract gave spectroscopic data
that was indicative of a complex mixture of closely related
glycolipids. LR-FAB-MS analysis of the mixture revealed a
series of clusters of molecular ions with centres at m/z 1918,
1
932, 1944, 1961, 1973, 1988, 2003, 2015, and 2046. The
1
13
H and C NMR spectra of the mixture showed evidence for
the presence of a number of monosaccharide anomeric car-
bons, a large number of carbinol methines and methylenes,
extensive acetylation, and a long aliphatic chain. All chro-
matographic attempts to resolve the complex mixture of nat-
A very non-polar fraction, which contained a mixture of
the aglycon portions of the pachymosides, was also obtained
4
While the current study was underway, another group reported screening a chemical library for inhibition of YopE transcription with a luci-
ferase reporter assay, yielding three compounds that inhibited the reporter signal expressed from the yopE promoter and effector protein se-
cretion with little effect on bacterial growth (15). One compound appears to be affecting type III regulation, and this and one other
compound are specific to the virulence-associated TTSS, and do not affect flagellum assembly and motility. Overall, these results are evi-
dence in support of TTSS-specific inhibitors, although the bacterial target(s) and ability to inhibit TTSS in infected host cells awaits further
study.
©
2003 NRC Canada